शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEAdline Chem Lab Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 12 Nov, 2025 · 18:56 IST

Resignation of Chairman and Managing Director

CEO resignedKey managerial personnel resignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.9%Reaction day
₹12.78
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-4.8% vs market
Pharmaceuticals peers, median of 157sector-0.0%-4.9% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 4.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.9-0.1-4.8-0.0-4.9
Next day
-8.5-0.2-8.3-0.4-8.0
2d
-12.8+0.4-13.2-0.3-12.4
3d
-17.1-0.4-16.7-1.0-16.0
4d
-21.0-0.6-20.4-1.3-19.7
5d
-24.4-0.9-23.5-1.5-22.9
1w
—-3.0—-3.3—
15d
—-3.9—-3.4—
1m
-37.6-4.8-32.7-4.0-33.5
2m
-16.7-7.8-8.9-6.6-10.0
3m
—-7.2—-8.7—
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Two directors of Adline Chem Lab Ltd resigned with effect from the close of business hours on November 12, 2025. Mr. Sarang Bharatbhai Pathak (DIN: 02663344) stepped down from the post of Executive Director-Chairperson, who also served as Managing Director. Mr. Hemant Amrish Parikh (DIN: 00027820) resigned as Non-Executive Promoter Director and also stepped off the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees. Both cited 'personal and other pre-occupations' and confirmed there were no other material reasons for their exit. The Board has reconstituted all four board committees effective November 13, 2025, with Mr. Vrushank Balkrushna Patel (Executive, Promoter) and Mr. Dhawal Akhilesh Deopora (Independent) taking key roles.

Likely market impact

The same-day exit of both the Chairman/MD and a promoter director may raise short-term governance and leadership-continuity concerns, though no material undisclosed reasons were flagged. Investors should watch for clarity on interim leadership and any further board changes.